Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2018-07
-
SW033291: Advancing 15-PGDH Inhibitor Research in Regenerati
2026-06-17
Explore SW033291, a powerful 15-PGDH inhibitor, and its impact on prostaglandin E2 elevation, tissue regeneration, and hematopoietic stem cell expansion. This article provides a unique, protocol-oriented perspective bridging molecular pharmacology and regenerative biology.
-
Hypoxia-Induced S100A10 Drives Glioblastoma Malignancy and D
2026-06-17
This study uncovers S100A10 as a hypoxia-responsive driver of glioblastoma (GBM) malignancy and chemoresistance through activation of the PI3K-AKT pathway. By integrating multi-omics analysis and functional assays, the work clarifies how S100A10 upregulation under hypoxic conditions impairs apoptosis and enhances glioma progression, offering new insights for targeting drug-resistant GBM.
-
Targeting Glutamine Metabolism in Hepatic Stellate Cells to
2026-06-16
This study demonstrates that modulating glutamine metabolism, specifically via SIRT4-mediated inhibition of glutamate dehydrogenase (GDH), reduces hepatic stellate cell activation and liver fibrosis progression. The findings highlight a potential new therapeutic strategy and provide mechanistic insights for metabolic interventions in chronic liver disease.
-
Elevating Apoptosis Detection: Strategic Insights for Transl
2026-06-16
This article provides a thought-leadership perspective on the mechanistic and translational imperatives of apoptosis detection, with a focus on the One-step TUNEL FITC Apoptosis Detection Kit. Integrating recent findings in neurodevelopmental toxicity and referencing emerging approaches in tissue and cell research, it delivers actionable guidance for optimizing DNA fragmentation assays in the context of disease modeling and therapeutic discovery.
-
Phos binding reagent (Phosbind) acrylamide: Protocol and QC
2026-06-15
Phos binding reagent (Phosbind) acrylamide enables phosphorylation-dependent protein mobility shift detection during SDS-PAGE, without the need for phospho-specific antibodies. It is best suited for analyzing proteins in the 30–130 kDa range under standard Tris-glycine buffer conditions. This reagent is not optimal for targets outside this molecular range, or workflows requiring long-term reagent storage.
-
CHIR-99021 (CT99021): Precision in Stem Cell Differentiation
2026-06-15
CHIR-99021 (CT99021) enables reproducible control of Wnt/β-catenin and TGF-β/Nodal signaling for advanced stem cell workflows. Leverage its selectivity to optimize co-differentiation protocols and generate vascularized tissue models, with actionable troubleshooting and protocol refinements.
-
Leupeptin Hemisulfate Salt: Precision in Protease Activity R
2026-06-14
Leupeptin hemisulfate salt empowers researchers with robust, evidence-based control over serine and cysteine protease activity in protein degradation, viral replication, and macroautophagy workflows. This comprehensive guide details protocol enhancements, advanced applications, and troubleshooting insights that maximize the reproducibility and translational impact of APExBIO’s Leupeptin, Microbial.
-
Dual-Action p38α MAPK Inhibitors Enhance Kinase Dephosphoryl
2026-06-13
This study reveals that certain p38α MAPK inhibitors, beyond blocking kinase activity, also promote dephosphorylation of the activation loop by phosphatases. These findings offer structural and mechanistic insights for designing more selective and potent kinase inhibitors, with implications for inflammation and disease modeling.
-
Ac-YVAD-CMK: Applied Workflows for Inflammatory Cytokine Inh
2026-06-12
Ac-YVAD-CMK (N-Ac-Tyr-Val-Ala-Asp-CMK) enables precise suppression of Caspase-1-driven cytokine release, facilitating advanced studies of pyroptosis and liver inflammation. This guide details protocol enhancements, troubleshooting, and translational insights from TMEM16F research, helping researchers maximize assay clarity when dissecting anti-inflammatory mechanisms.
-
MLKL-Induced Lysosomal Permeabilization Drives Necroptosis v
2026-06-12
This study reveals a mechanistic link between MLKL polymerization and lysosomal membrane permeabilization (LMP) as a key event in necroptosis, leading to the cytosolic release of cathepsin B and subsequent cell death. The findings clarify the sequence of cellular events during necroptosis and highlight cathepsin B as a viable intervention target for modulating programmed necrotic cell death.
-
EGCG in Translational Research: Mechanistic Insights & Strat
2026-06-11
This article explores the mechanistic versatility and translational strategies for (-)-Epigallocatechin gallate (EGCG), highlighting recent breakthroughs in antibacterial, antiangiogenic, and cancer chemoprevention research. Leveraging cutting-edge findings, including novel analog development for intracellular Staphylococcus aureus, we provide actionable guidance for translational scientists seeking robust, reproducible workflows and advanced applications using APExBIO’s high-purity EGCG.
-
Ultrasensitive Fluorescence: Translating TSA to Cancer Biolo
2026-06-11
Explore the transformative impact of the Fluorescein TSA Fluorescence System Kit on the detection of low-abundance biomolecules in cancer research. With a focus on mechanistic insight, strategic workflow optimization, and translational value, this article bridges advanced fluorescence amplification technology with practical guidance for investigators studying lipid metabolism, miRNA regulation, and beyond.
-
AMPK Suppresses Autophagy Initiation Under Energy Stress
2026-06-10
This study redefines the role of AMPK in cellular energy stress, revealing that AMPK inhibits, rather than stimulates, autophagy initiation by directly suppressing ULK1 activity during glucose starvation. These findings inform more precise approaches to modulating autophagy and vesicle trafficking in disease models.
-
BODIPY 581/591 C11: Ratiometric Fluorescent Probe for Lipid
2026-06-10
BODIPY 581/591 C11 empowers researchers with ratiometric, high-sensitivity lipid peroxidation detection in live cells and membrane systems. Its robust red-to-green spectral shift, photostability, and selectivity for reactive oxygen species enable quantitative oxidative stress measurement and streamlined antioxidant evaluation.
-
Dietary Arachidonic Acid Accelerates Humoral Vaccine Immunit
2026-06-09
A recent study demonstrates that dietary supplementation with arachidonic acid (ARA), a polyunsaturated omega-6 fatty acid, significantly enhances the speed and magnitude of vaccine-induced neutralizing antibody responses in both mice and humans. This finding highlights a metabolic–immunological mechanism in which ARA-derived eicosanoids promote germinal center B cell maturation, with potential to inform rapid immunization strategies and dietary adjuvant design.